BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37803205)

  • 1. Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study.
    Simons CL; Hwu WL; Zhang R; Simons MJHG; Bergkvist M; Bennison C
    Adv Ther; 2023 Dec; 40(12):5399-5414. PubMed ID: 37803205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eladocagene Exuparvovec: First Approval.
    Keam SJ
    Drugs; 2022 Sep; 82(13):1427-1432. PubMed ID: 36103022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency.
    Tai CH; Lee NC; Chien YH; Byrne BJ; Muramatsu SI; Tseng SH; Hwu WL
    Mol Ther; 2022 Feb; 30(2):509-518. PubMed ID: 34763085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for aromatic L-amino acid decarboxylase deficiency: Requirements for safe application and knowledge-generating follow-up.
    Roubertie A; Opladen T; Brennenstuhl H; Kuseyri Hübschmann O; Flint L; Willemsen MA; Leuzzi V; Cazorla AG; Kurian MA; François-Heude MC; Hwu P; Zeev BB; Kiening K; Roujeau T; Pons R; Pearson TS
    J Inherit Metab Dis; 2024 May; 47(3):463-475. PubMed ID: 37402126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraputaminal Gene Delivery in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency.
    François-Heude MC; Poulen G; Flamand Roze E; Nguyen Morel MA; Gras D; Roch-Toreilles I; Quintard A; Baroux G; Meyer P; Coubes P; Milesi C; Cambonie G; Baleine J; Sola C; Delye B; Dimopoulou E; Sanchez S; Gasnier M; Touati S; Zamora A; Pontal D; Leboucq N; Kouyoumdjian V; Lebasnier A; Sanquer S; Mariano-Goulart D; Roujeau T; Roubertie A
    Mov Disord Clin Pract; 2023 May; 10(5):811-818. PubMed ID: 37205256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients.
    Lee HM; Mercimek-Andrews S; Horvath G; Marchese D; Poulin RE; Krolick A; Tierney KL; Turna J; Wei J; Hwu WL
    Orphanet J Rare Dis; 2024 Jan; 19(1):17. PubMed ID: 38238766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France.
    Smith AB; Hanbury A; Beitia Ortiz de Zarate I; Hammes F; de Pouvourville G; Buesch K
    Patient Relat Outcome Meas; 2021; 12():237-246. PubMed ID: 34285619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and impact of aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a patient-centred conceptual model.
    Williams K; Skrobanski H; Werner C; O'Neill S; Buesch K; Acaster S
    Curr Med Res Opin; 2021 Aug; 37(8):1353-1361. PubMed ID: 34042550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms and impacts of aromatic L-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function.
    Williams K; Skrobanski H; Buesch K; Acaster S
    Orphanet J Rare Dis; 2022 Mar; 17(1):128. PubMed ID: 35313922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatic L-amino acid decarboxylase deficiency in countries in the Middle East: a case series and literature review.
    Abukhaled M; Al Muqbil M; Alghamdi MA; Hundallah K; Suleiman J; Ben-Omran T; Alfadhel M; Almannai M; Alsaleh R; Tabarki B
    Eur J Pediatr; 2023 Jun; 182(6):2535-2545. PubMed ID: 36928758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV2-hAADC (Eladocagene Exuparvovec) Biodistribution and Expression: Superiority of Intraputaminal versus Intracerebroventricular and Intrathecal (Lumbar) Routes of Administration.
    Compton DR; DeMarco SJ; Yalamanchili P
    Int J Toxicol; 2023; 42(2):135-145. PubMed ID: 36472076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Aromatic l-Amino Acid Decarboxylase Deficiency in At-Risk Populations.
    Hyland K; Reott M
    Pediatr Neurol; 2020 May; 106():38-42. PubMed ID: 32111562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deriving Vignettes for the Rare Disease AADC Deficiency Using Parent, Caregiver and Clinician Interviews to Evaluate the Impact on Health-Related Quality of Life.
    Hanbury A; Smith AB; Buesch K
    Patient Relat Outcome Meas; 2021; 12():1-12. PubMed ID: 33447119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy for Dopamine Dyshomeostasis: From Parkinson's to Primary Neurotransmitter Diseases.
    Ng J; Barral S; Waddington SN; Kurian MA
    Mov Disord; 2023 Jun; 38(6):924-936. PubMed ID: 37147851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of caring for an individual with aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a conceptual model.
    Skrobanski H; Williams K; Werner C; O'Neill S; Buesch K; Acaster S
    Curr Med Res Opin; 2021 Oct; 37(10):1821-1828. PubMed ID: 34259573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical diagnosis of aromatic-L-amino acid decarboxylase deficiency (AADCD) by assay of AADC activity in plasma using liquid chromatography/tandem mass spectrometry.
    Civallero G; Kubaski F; Pereira D; Rübensam G; Herbst ZM; Silva C; Trapp FB; Poletto E; Faqueti L; Iop G; Soares J; van der Linden V; van der Linden H; Lourenço CM; Giugliani R
    Mol Genet Metab Rep; 2022 Sep; 32():100888. PubMed ID: 35769135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier frequency and incidence of aromatic L-amino acid decarboxylase deficiency: a gnomAD-based study.
    Park JE; Lee T; Ha K; Cho EH; Ki CS
    Pediatr Res; 2023 Nov; 94(5):1764-1770. PubMed ID: 37286773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial.
    Chien YH; Lee NC; Tseng SH; Tai CH; Muramatsu SI; Byrne BJ; Hwu WL
    Lancet Child Adolesc Health; 2017 Dec; 1(4):265-273. PubMed ID: 30169182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic l-amino acid decarboxylase deficiency: a patient-derived neuronal model for precision therapies.
    Rossignoli G; Krämer K; Lugarà E; Alrashidi H; Pope S; De La Fuente Barrigon C; Barwick K; Bisello G; Ng J; Counsell J; Lignani G; Heales SJR; Bertoldi M; Barral S; Kurian MA
    Brain; 2021 Sep; 144(8):2443-2456. PubMed ID: 33734312
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.